ArticleWorld journal of urology2021

Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatment.

Shaheen Alanee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.